semaglutide and gallstones Are (cholelithiasis) a contraindication to therapy? Ozempic and Gallstones: Safe Weight

Any exposure to mycotoxins can contribute to Leaky Gut

Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin

Abrupt stopping of long-term acid suppression can cause rebound symptoms and should always be medically supervised

There was a significant 24% reduction in the composite primary outcome in the semaglutide group compared with those taking placebo, with first events occurring in 5.8 versus 7.5 people per 100 person-years of follow-up, such that 20 people would need to be treated for 3 years to prevent one primary event

In aortic aneurysm, degradation products of the glycocalyx, syndecans, may serve as biomarkers and therapeutic targets (35)

Eli Lilly and Novartis (speakers bureau